|
1
|
Beke A, Piko H, Haltrich I, Csomor J,
Matolcsy A, Fekete G, Rigo J and Karcagi V: Molecular cytogenetic
analysis of Xq critical regions in premature ovarian failure. Mol
Cytogenet. 6:622013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goswami D and Conway GS: Premature ovarian
failure. Horm Res. 68:196–202. 2007.PubMed/NCBI
|
|
3
|
Ghassemzadeh A, Farzadi L and Beyhaghi E:
Premature ovarian failure risk factors in an Iranian population.
Int J Gen Med. 5:335–338. 2012.PubMed/NCBI
|
|
4
|
Conway GS, Kaltsas G, Patel A, Davies MC
and Jacobs HS: Characterization of idiopathic premature ovarian
failure. Fertil Steril. 65:337–341. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wittenberger MD, Hagerman RJ, Sherman SL,
McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL and
Nelson LM: The FMR1 premutation and reproduction. Fertil Steril.
87:456–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuang YB: IL-2, IL-6 expression in
autoimmune premature ovarian failure and its clinical significance.
Chin J Contemp Med. 15:46–47. 2015.
|
|
7
|
Sawalha AH, Kaufman KM, Kelly JA, Adler
AJ, Aberle T, Kilpatrick J, Wakeland EK, Li QZ, Wandstrat AE, Karp
DR, et al: Genetic association of interleukin-21 polymorphisms with
systemic lupus erythematosus. Ann Rheum Dis. 67:458–461. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knauff EA, Eijkemans MJ, Lambalk CB, ten
Kate-Booij MJ, Hoek A, Beerendonk CC, Laven JS, Goverde AJ,
Broekmans FJ, Themmen AP, et al; Dutch Premature Ovarian Failure
Consortium, . Anti-Mullerian hormone, inhibin B, and antral
follicle count in young women with ovarian failure. J Clin
Endocrinol Metab. 94:786–792. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vital Reyes VS, Téllez Velasco S, Hinojosa
Cruz JC, Ortiz Romero Mde J, Chavarría Olarte ME and Reyes Fuentes
A: Serum levels of IL-1beta, IL-6 and TNF-alpha in infertile
patients with ovarian dysfunction. Ginecol Obstet Mex. 73:604–610.
2005.(In Spanish). PubMed/NCBI
|
|
10
|
Chernyshov VP, Radysh TV, Gura IV,
Tatarchuk TP and Khominskaya ZB: Immune disorders in women with
premature ovarian failure in initial period. Am J Reprod Immunol.
46:220–225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dayer JM and Choy E: Therapeutic targets
in rheumatoid arthritis: The interleukin-6 receptor. Rheumatology
(Oxford). 49:15–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dienz O, Eaton SM, Bond JP, Neveu W,
Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G,
et al: The induction of antibody production by IL-6 is indirectly
mediated by IL-21 produced by CD4+ T cells. J Exp Med.
206:69–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Youinou P and Jamin C: The weight of
interleukin-6 in B cell-related autoimmune disorders. J Autoimmun.
32:206–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Benedetti F: Targeting interleukin-6 in
pediatric rheumatic diseases. Curr Opin Rheumatol. 21:533–537.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spolski R and Leonard WJ: Interleukin-21:
Basic biology and implications for cancer and autoimmunity. Annu
Rev Immunol. 26:57–79. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Niu X, He D, Zhang X, Yue T, Li N, Zhang
JZ, Dong C and Chen G: IL-21 regulates Th17 cells in rheumatoid
arthritis. Hum Immunol. 71:334–341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coulam CB, Kempers RD and Randall RV:
Premature ovarian failure: Evidence for the autoimmune mechanism.
Fertil Steril. 36:238–240. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng R, Spolski R, Casas E, Zhu W, Levy DE
and Leonard WJ: The molecular basis of IL-21-mediated
proliferation. Blood. 109:4135–4142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nurieva R, Yang XO, Martinez G, Zhang Y,
Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, et
al: Essential autocrine regulation by IL-21 in the generation of
inflammatory T cells. Nature. 448:480–483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
La Marca A, Stabile G, Artenisio AC and
Volpe A: Serum anti-Mullerian hormone throughout the human
menstrual cycle. Hum Reprod. 21:3103–3107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li HW, Lee VC, Lau EY, Yeung WS, Ho PC and
Ng EH: Role of baseline antral follicle count and anti-Mullerian
hormone in prediction of cumulative live birth in the first in
vitro fertilisation cycle: A retrospective cohort analysis. PLoS
One. 8:e610952013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Méduri G, Massin N, Guibourdenche J,
Bachelot A, Fiori O, Kuttenn F, Misrahi M and Touraine P: Serum
anti-Müllerian hormone expression in women with premature ovarian
failure. Hum Reprod. 22:117–123. 2007. View Article : Google Scholar : PubMed/NCBI
|
